Amylin Agonists: A Novel Approach in the Treatment of Diabetes

Amylin is a peptide hormone that is cosecreted with insulin from the pancreatic beta-cell and is thus deficient in diabetic people. It inhibits glucagon secretion, delays gastric emptying, and acts as a satiety agent. Amylin replacement could therefore possibly improve glycemic control in some peopl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2004-12, Vol.53 (suppl 3), p.S233-S238
Hauptverfasser:	SCHMITZ, Ole, BROCK, Birgitte, RUNGBY, Jorgen
Format:	Artikel
Sprache:	eng
Schlagworte:	Amyloid - agonists Amyloid - physiology Amyloid - therapeutic use Animals Binding sites Biological and medical sciences Clinical trials Clinical Trials as Topic Diabetes Diabetes Mellitus - drug therapy Diabetes. Impaired glucose tolerance Disease Models, Animal Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Glucagon Glucose Glycated Hemoglobin A - drug effects Glycated Hemoglobin A - metabolism Humans Hypoglycemia Insulin - therapeutic use Insulin resistance Islet Amyloid Polypeptide Medical sciences Metabolism Peptides Physiology Signal transduction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!